Chromosomes, genes, and development of testicular germ cell tumors

Cancer Genetics and Cytogenetics

Volumn 151, Issue 2, 2004, Pages 93-138

  Von Eyben, Finn Edler ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D2; CYCLIN DEPENDENT KINASE INHIBITOR; PROTEIN P16; PROTEIN P18; PROTEIN P19; PROTEIN P21; PROTEIN P27;

CARCINOGENESIS; CHROMOSOME; CHROMOSOME 11P; CHROMOSOME 11Q; CHROMOSOME 12P; CHROMOSOME 13Q; CHROMOSOME 17Q; CHROMOSOME 18Q; CHROMOSOME 21Q; CHROMOSOME 22Q; CHROMOSOME 4Q; CHROMOSOME 5Q; CHROMOSOME 7P; CHROMOSOME 7Q; CHROMOSOME 8Q; CHROMOSOME ABERRATION; CHROMOSOME XQ; DOWN REGULATION; GENE; GENE EXPRESSION; GENE MUTATION; GERM CELL TUMOR; HUMAN; PRECURSOR; PRIORITY JOURNAL; PROTO ONCOGENE; RETINOBLASTOMA; REVIEW; SEMINOMA; TRIPLOIDY; UPREGULATION;

EID: 2542458344     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2003.09.008     Document Type: Article

References (275)

1. Mertens F., Johansson B., Mitelman F. Isochromosomes in neoplasia. Genes Chromosomes Cancer. 10:1994;221-230
2. Sandberg A.A., Meloni A.M., Suijkerbuijk R.F. Reviews of chromosome studies in urological tumors III. Cytogenetics and genes in testicular tumors. J Urol. 155:1996;1531-1556
3. de Jong B., Oosterhuis J.W., Castedo S.M., Vos A., te Meerman G.J. Pathogenesis of adult testicular germ cell tumors: a cytogenetic model. Cytogenet Cell Genet. 48:1990;143-167
4. Mostofi F.K., Sesterhenn I.A., Sobin L.H. Histological typing of testis tumours. 2nd edition. World Health Organisation. International classification of tumours. 1998;Springer-Verlag, Berlin, New York
5. Teilum G. Classification of endodermal sinus tumour (mesoblastoma vitellinum) and so-called "embryonal carcinoma" of the ovary. [Review] Acta Pathol Microbiol Scand. 64:1965;407-429
6. International Germ Cell Cancer Collaborative Group. International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. J Clin Oncol. 15:1997;594-603
7. Skakkebaek N.E. Possible carcinoma-in-situ of the testis. Lancet. 2:(7776):1972;516-517
8. Skakkebaek N.E., Berthelsen J.G., Giwercman A., Muller J. Carcinoma-in-situ of the testis: possible origin from gonocytes and precursor of all types of germ cell tumours except spermatocytoma. Int J Androl. 10:1987;19-28
9. Holstein A.F., Schutte B., Becker H., Hartmann M. Morphology of normal testis and malignant germ cells. Int J Androl. 10:1987;1-10
10. Bartkova J., Falck J., Rajpert-De Meyts E., Skakkebaek N.E., Lukas J., Bartek J. Chk2 tumour suppressor protein in human spermatogenesis and testicular germ-cell tumours. Oncogene. 20:2001;5897-5902
11. INK4d in human testicular germ-cell tumours contrasts with high expression during normal spermatogenesis. Oncogene. 19:2000;4146-4150
12. de Graaff W.E., Oosterhuis J.W., de Jong B., Dam A., van Putten W.L., Castedo S.M., Sleijfer D.T., Schraffordt Koops H. Ploidy of testicular carcinoma in situ. Lab Invest. 66:1992;166-168
13. Skotheim R.I., Monni O., Mousses S., Fosså S.D., Kallioniemi O.P., Lothe R., Kallioniemi A. New insights into testicular germ cell tumorigenesis from gene expression profiling. Cancer Res. 62:2002;2359-2364
14. von Eyben F.E., Mikulowski P., Busch C. Microinvasive germ cell tumors of the testis. J Urol. 126:1981;842-844
15. von Eyben F.E., Hoyer P.E., Busch C. Microspectrophotometric observations of a microinvasive testicular germ cell tumor. Jones W.G., Ward A.M., Anderson C.K. Germ cell tumours II: Proceedings of the 2nd Germ Cell Tumour Conference, Leeds, 15-19 April 1985. 1986;57-58 Pergamon Press, Oxford
16. Mikulowski P., Oldbring J. Microinvasive germ cell neoplasia of the testis. Cancer. 70:1992;659-664
17. Nowell P.C. Tumor progression: a brief historical perspective. [Review] Semin Cancer Biol. 12:2002;261-266
18. Vogelstein B., Fearon E.R., Hamilton S.R., Kern S.E., Preisinger A.C., Leppert M., Nakamura Y., White B., Smits A.M., Bos J.L. Genetic alterations during colorectal-tumor development. N Engl J Med. 319:1988;525-532
19. Fearon E.R., Vogelstein B. A genetic model of colorectal tumorigenesis. Cell. 61:1990;759-767
20. Summersgill B., Osin P., Lu Y.J., Huddart R., Shipley J. Chromosomal imbalances associated with carcinoma in situ and associated testicular germ cell tumours of adolescents and adults. Br J Cancer. 85:2001;213-220
21. Wang N., Trend B., Bronson D.L., Fraley E.E. Nonrandom abnormalities in chromosome 1 in human testicular cancers. Cancer Res. 40:1980;796-802
22. Mishina M., Ogawa O., Kinoshita H., Oka H., Okumura K., Mitsumori K., Kakehi Y., Reeve A.E., Yoshida O. Equivalent parental distribution of frequently lost alleles and biallelic expression of the H19 gene in human testicular germ cell tumors. Jpn J Cancer Res. 87:1996;816-823
23. Murty V.V., Chaganti R.S. A genetic perspective of male germ cell tumors. [Review] Semin Oncol. 25:1998;133-144
24. Murty V.V., Li R.G., Mathew S., Reuter V.E., Bronson D.L., Bosl G.J., Chaganti R.S. Replication error-type genetic instability at 1q42-43 in human male germ cell tumors. Cancer Res. 54:1994;3983-3985
25. Murty V.V., Bosl G.J., Houldsworth J., Meyers M., Mukherjee A.B., Reuter V., Chaganti R.S. Allelic loss and somatic differentiation in human male germ cell tumors. Oncogene. 9:1994;2245-2251
26. Rodriguez E., Mathew S., Reuter V., Ilson D.H., Bosl G.J., Chaganti R.S. Cytogenetic analysis of 124 prospectively ascertained male germ cell tumors. Cancer Res. 52:1992;2285-2291
27. Mathew S., Murty V.V., Bosl G.J., Chaganti R.S. Loss of heterozygosity identifies multiple sites of allelic deletions on chromosome 1 in human male germ cell tumors. Cancer Res. 54:1994;6265-6269
28. Korn W.M., Oide M., Weghuis D.E., Suijkerbuijk R.F., Schmidt U., Otto T., Du Manoir S., Geurts van Kessel A., Harstrick A., Seeber S., Becher R. Detection of chromosomal DNA gains and losses in testicular germ cell tumors by comparative genomic hybridization. Genes Chromosomes Cancer. 17:1996;78-87
29. Summersgill B., Goker H., Weber Hall S., Huddart R., Horwich A., Shipley J. Molecular cytogenetic analysis of adult testicular germ cell tumours and identification of regions of consensus copy number change. Br J Cancer. 77:1998;305-313
30. Summersgill B.M., Jafer O., Wang R., Goker H., Niculescu-Duvaz I., Huddart R., Shipley J. Definition of chromosome aberrations in testicular germ cell tumour cell lines by 24-color karyotyping and complementary molecular cytogenetic analyses. Cancer Genet Cytogenet. 128:2001;120-129
31. Ottesen A.M., Kirchhoff M., Rajpert-De Meyts E., Maahr J., Gerdes T., Rose H., Lundsteen C., Petersen P.M., Philip J., Skakkebaek N.E. Detection of chromosomal aberrations in seminomatous germ cell tumours using comparative genomic hybridization. Genes Chromosomes Cancer. 20:1997;412-418
32. Walt H., Emmerich P., Cremer T., Hofmann M.C., Bannwart F. Supernumerary chromosome 1 in interphase nuclei of atypical germ cells in paraffin-embedded human seminiferous tubules. Lab Invest. 61:1989;527-531
33. Kraggerud S.M., Skotheim R.I., Szymanska J., Eknaes M., Fosså S.D., Stenwig A.E., Peltomaki P., Lothe R.A. Genome profiles of familial/bilateral and sporadic testicular germ cell tumors. Genes Chromosomes Cancer. 34:2002;168-174
34. Looijenga L.H., Rosenberg C., van Gurp R.J., Geelen E., van Echten-Arends J., de Jong B., Mostert M., Oosterhuis J.W. Comparative genomic hybridization and microdissection samples from different stages in the development of a seminoma and a nonseminoma. J Pathol. 191:2000;187-192
35. Lothe R.A., Peltomaki P., Tommerup N., Fosså S.D., Stenwig A.E., Børresen A.L., Nesland J.M. Molecular genetic changes in human male germ cell tumors. Lab Invest. 73:1995;606-614
36. Lothe R.A., Fosså S.D., Stenwig A.E., Nakamura Y., White R., Børresen A.L., Brogger A. Loss of 3p and 11p alleles is associated with testicular cancer tumors. Genomics. 5:1989;134-138
37. Skotheim R.I., Kraggerud S.M., Fosså S.D., Stenwig A.E., Gedde-Dahl T. Jr., Danielsen H.E., Jacobsen K.S., Lothe R.A. Familial/bilateral and sporadic testicular germ cell tumors show frequent genetic changes at loci with suggestive linkage evidence. Neoplasia. 3:2001;196-203
38. Faulkner S.W., Leigh D.A., Oosterhuis J.W., Looijenga L.H., Friedlander M.L. Allelic losses in carcinoma in situ and testicular germ cell tumours of adolescents and adults: evidence suggestive of the linear progression model. Br J Cancer. 83:2000;729-736
39. Murty V.V., Reuter V.E., Bosl G.J., Chaganti R.S. Deletion mapping identifies loss of heterozygosity at 5p15.1-15.2, 5q11 and 5q34-35 in human male germ cell tumors. Oncogene. 12:1996;2719-2723
40. al-Jehani R.M., Povey S., Delhanty J.D., Parrington J.M. Loss of heterozygosity on chromosome arms 5q, 11p, 11q, 13q, and 16p in human testicular germ cell tumors. Genes Chromosomes Cancer. 13:1995;249-256
41. Peng H.Q., Liu L., Goss P.E., Bailey D., Hogg D. Chromosomal deletions occur in restricted regions of 5q in testicular germ cell cancer. Oncogene. 18:1999;3277-3283
42. Lothe R.A., Hastie N., Heimdal K., Fosså S.D., Stenwig A.E., Børresen A.L. Frequent loss of 11p13 and 11p15 in male germ cell tumours. Genes Chromosomes Cancer. 7:1993;96-101
43. Smith R.C., Rukstalis D.B. Frequent loss of heterozygosity at 11p loci in testicular cancer. J Urol. 153:1995;1684-1687
44. Looijenga L.H., Gillis A.J., van Putten W.L., Oosterhuis J.W. In situ numeric analysis of centrometric regions of chromosomes 1, 12, and 15 of seminomas, nonseminomatous germ cell tumors, and carcinoma in situ of human testis. Lab Invest. 68:1993;211-219
45. Samaniego F., Rodriguez E., Houldsworth J., Murty V.V., Ladanyi M., Lele K.P., Chen Q., Dmitrovsky E., Geller N., Reuter V., Jhanwar S.C., Bosl G.J., Chaganti R.S. Cytogenetic and molecular analysis of human male germ cell tumors: chromosome 12 abnormalities and gene amplification. Genes Chromosomes Cancer. 1:1990;289-300
46. Rosenberg C., Schut T.B., Mostert M., Tanke H., Raap A., Oosterhuis J.W., Looijenga L. Chromosomal gains and losses in testicular germ cell tumors of adolescents and adults investigated by a modified comparative genomic hybridization approach. Lab Invest. 79:1999;1447-1451
47. Rodriguez S., Jafer O., Goker H., Summersgill B.M., Zafarana G., Gillis A.J., van Gurp R.J., Oosterhuis J.W., Lu Y.J., Huddart R., Cooper C.S., Clark J., Looijenga L.H., Shipley J.M. Expression profile of genes from 12p in testicular germ cell tumors of adolescents and adults associated with i(12p) and amplification at 12p11.2-p12.1. Oncogene. 22:2003;1880-1891
48. Rosenberg C., van Gurp R.J., Geelen E., Oosterhuis J.W., Looijenga L.H. Overrepresentation of the short arm of chromosome 12 is related to invasive growth of human testicular seminomas and nonseminomas. Oncogene. 19:2000;5858-5862
49. Murty V.V., Renault B., Falk C.T., Bosl G.J., Kucherlapati R., Chaganti R.S. Physical mapping of a commonly deleted region, the site of a candidate tumor suppressor gene, at 12q22 in human male germ cell tumors. Genomics. 35:1996;562-570
50. Murty V.V., Houldsworth J., Baldwin S., Reuter V., Hunziker W., Besmer P., Bosl G., Chaganti R.S. Allelic deletions in the long arm of chromosome 12 identify sites of candidate tumor suppressor genes in male germ cell tumors. Proc Natl Acad Sci U S A. 89:1992;11006-11010
51. Murty V.V., Montgomery K., Dutta S., Bala S., Renault B., Bosl G.J., Kucherlapati R., Chaganti R.S. A 3-Mb high-resolution BAC/PAC contig of 12q22 encompassing the 830-kb consensus minimal deletion in male germ cell tumors. Genome Res. 9:1999;662-671
52. Rapley E.A., Crockford G.P., Teare D., Biggs P., Seal S., Barfoot R., Edwards S., Hamoudi R., Heimdal K., Fosså S.D., Tucker K., Donald J., Collins F., Fridlander M., Hogg D., Goss P., Heidenreich A., Ormiston W., Daly P.A., Forman D., Oliver T.D., Leahy M., Huddart R., Cooper C.S., Bodmer J.G., Easton D.F., Stratton M.R., Bishop D.T. Localization to Xq27 of a susceptibility gene for testicular germ-cell tumours. Nat Genet. 24:2000;197-200
53. Theiss E.A., Ashley D.J., Mostofi F.K. Nuclear sex of testicular tumors and some related ovarian and extragonadal neoplasms. Cancer. 13:1960;323-327
54. Atkin N.B., Baker M.C. X-chromatin, sex chromosomes, and ploidy in 37 germ cell tumors of the testis. Cancer Genet Cytogenet. 59:1992;54-56
55. Looijenga L.H., Gillis A.J., van Gurp R.J., Verkerk A.J., Oosterhuis J.W. X inactivation in human testicular tumors: XIST expression and androgen receptor methylation status. Am J Pathol. 151:1997;581-590
56. von Eyben F.E., Holzik M.L. Alpha fetoprotein, tumor histology, and copy number of isochromosome i(12p) in testicular germ cell tumors. J Tumor Marker Oncol. 17:2002;5-11
57. Bartkova J., Rajpert-De Meyts E., Skakkebaek N.E., Lukas J., Bartek J. Deregulation of the G1/S-phase control in human testicular germ cell tumours. APMIS. 111:2003;252-266
58. Heim S., Mitelman F. Cancer cytogenetics. 1987;Alan R. Liss, New York
59. International Testicular Cancer Linkage Consortium. Candidate regions for testicular cancer susceptibility genes. APMIS. 106:1998;64-70. discussion 71-2
60. Rapley E.A., Crockford G.P., Easton D.F., Stratton M.R., Bishop D.T. Localisation of susceptibility genes for familial testicular germ cell tumour. APMIS. 111:2003;128-135
61. Rajpert-De Meyts E., Skakkebaek N.E. Expression of the c-kit protein product in carcinoma-in-situ and invasive testicular germ cell tumours. Int J Androl. 17:1994;85-92
62. Meng X., de Rooij D.G., Westerdahl K., Saarma M., Sariola H. Promotion of seminomatous tumors by targeted overexpression of glial line-derived neurotrophic factor in mouse testis. Cancer Res. 61:2001;3267-3271
63. Viglietto G., Dolci S., Bruni P., Baldassarre G., Chiariotti L., Melillo R.M., Salvatore G., Chiappetta G., Sferratore F., Fusco A., Santoro M. Glial cell line-derived neutrotrophic factor and neurturin can act as paracrine growth factors stimulating DNA synthesis of Ret-expressing spermatogonia. Int J Oncol. 16:2000;689-694
64. Olie R.A., Looijenga L.H., Dekker M.C., de Jong F.H., van Dissel-Emiliani F.M., de Rooij D.G., van der Holt B., Oosterhuis J.W. Heterogeneity in the in vitro survival and proliferation of human seminoma cells. Br J Cancer. 71:1995;13-17
65. Oosterhuis J.W., Gillis A.J., Looijenga L.H. In vitro survival, RAS mutations, apoptosis and activation of the SAPK-pathway in human seminoma cells. Jones W.G., Appleyard I., Harnden P., Jaffe J.K. Germ cell tumours IV: Proceedings of the 4th Germ Cell Tumour Conference, Leeds, November 1997. 1998;51-57 John Libbey & Company, London
66. Pera M.F., Bennett W., Cerretti D.P. CD30 and its ligand: possible role in regulation of teratoma stem cells. APMIS. 106:1998;169-173
67. Walsh J., Andrews P.W. Expression of Wnt and Notch pathway genes in a pluripotent human embryonal carcinoma cell line and embryonic stem cells. APMIS. 111:2003;197-211
68. Albanese J.M., Reuter V.E., Bosl G.J., Houldsworth J., Chaganti R.S. Expression of ID genes in differentiated elements of human male germ cell tumors. Diagn Mol Pathol. 10:2001;248-254
69. de Graaff W.E., Oosterhuis J.W., de Jong B., van Echten-Arends J., Wiersema-Buist J., Schraffordt Koops H., Sleijfer D.T. Cytogenetic analysis of the mature teratoma and the choriocarcinoma component of a testicular mixed nonseminomatous germ cell tumor. Cancer Genet Cytogenet. 61:1992;67-73
70. Ishiwata I., Ishiwata C., Soma M., Ono I., Nakaguchi T., Kiguchi K., Furusato M., Tachibana T., Hashimoto H., Ishikawa H. Establishment and characterization of human choriocarcinoma cell line derived from a metastatic focus of a testicular mixed germ cell tumor. Hum Cell. 12:1999;219-227
71. Eid H., Gulyas M., Geczi L., Bodrogi I., Institoris E., Bak M. Expression of bcl-2 in testicular carcinoma: correlation with tumor progression and MDR1/Pgp. Cancer. 83:1998;331-336
72. Strohmeyer T., Peter S., Hartmann M., Munemitsu S., Ackermann R., Ullrich A., Slamon D.J. Expression of the hst-1 and c-kit protooncogenes in human testicular germ cell tumors. Cancer Res. 51:1991;1811-1816
73. Kamai T., Arai K., Tsujii T., Honda M., Yoshida K. Overexpression of rhoA mRNA is associated with advanced stage in testicular germ cell tumour. BJU Int. 87:2001;227-231
74. Hiorns L.R., Seckl M.J., Paradinas F., Sharp S.Y., Skelton L.A., Brunstrom G., Newlands E.S., Kelland L.R., Leyland-Jones B. A molecular cytogenetic approach to studying platinum resistance. J Inorg Biochem. 77:1999;95-104
75. Meijer C., Timmer A., de Vries E., Groten J.P., Knol A., Zwart N., Dam W.A., Sleijfer D.T., Mulder N.H. Role of metallothionein in cisplatin sensitivity of germ-cell tumours. Int J Cancer. 85:2000;777-781
76. Wang X., Hafezparast M., Masters J.R. Genetic basis of drug sensitivity in human testis tumour cells. Int J Cancer. 65:1996;426-431
77. Lanfrancone L., Pelicci G., Pelicci P.G. Cancer genetics. [Review] Curr Opin Genet Dev. 4:1994;109-119
78. Koul S., Houldsworth J., Mansukhani M.M., Donadio A., McKiernan J.M., Reuter V.E., Bosl G.J., Chaganti R.S., Murty V.V. Characteristic promoter hypermethylation signatures in male germ cell tumors. Mol Cancer. 1:2002;8-17. (available from http://www.molecular-cancer.com/content/1/1/8)
79. Rao P.H., Houldsworth J., Palanisamy N., Murty V.V., Reuter V.E., Motzer R.J., Bosl G.J. Chromosomal amplification is associated with cisplatin resistance of human male germ cell tumors. Cancer Res. 58:1998;4260-4263
80. Mostert M.M., van de Pol M., Olde Weghuis D., Suijkerbuijk R.F., Geurts van Kessel A., van Echten J., Oosterhuis J.W., Looijenga L.H. Comparative genomic hybridization of germ cell tumors of the adult testis: confirmation of karyotypic findings and identification of a 12p-amplicon. Cancer Genet Cytogenet. 89:1996;146-152
81. von Eyben F.E. A systematic review of lactate dehydrogenase isoenzyme 1 and germ cell tumors. [Review] Clin Biochem. 34:2001;441-454
82. George D.W., Foster R.S., Hromas R.A., Robertson K.A., Vance G.H., Ulbright T.M., Gobbett T.A., Heiber D.J., Heerema N.A., Ramsey H.C., Thurston V.C., Jung S.H., Shen J., Finch D.E., Kelley M.R., Einhorn L.H. Update on late relapse of germ cell tumor: a clinical and molecular analysis. J Clin Oncol. 21:2003;113-122
83. de Graaf W.E., Sleijfer D.T., de Jong B., Dam A., Schraffordt Koops H., Oosterhuis J.W. Significance of aneuploid stemlines in testicular nonseminomatous germ cell tumors. Cancer. 72:1993;1300-1304
84. Mayer F., Gillis A.J., Dinjens W., Oosterhuis J.W., Bokemeyer C., Looijenga L.H. Microsatellite instability of germ cell tumors is associated with resistance to systemic treatment. Cancer Res. 62:2002;2758-2760
85. Mandoky L., Geczi L., Doleschall Z., Csuka O., Bodrogi I., Bak M. Lung resistance protein analysis in testicular cancer. [in Hungarian] Magy Onkol. 46:2002;339-345. [Hungarian Oncol]
86. von Eyben F.E. Laboratory markers and germ cell tumors [Review]. Crit Rev Clin Lab Sci. 40:2003;379-427
87. Bach A.M., Hann L.E., Shi W., Giess C.S., Yoo H.H., Sheinfeld J., Thaler H.T. Is there an increased incidence of contralateral testicular cancer in patients with intratesticular microlithiasis? AJR Am J Roentgenol. 180:2003;497-500
88. Summersgill B., Goker H., Osin P., Huddart R., Horwich A., Fisher C., Shipley J. Establishing germ cell origin of undifferentiated tumors by identifying gain of 12p material using comparative genomic hybridization analysis of paraffin-embedded samples. Diagn Mol Pathol. 7:1998;260-265
89. Kollmannsberger C., Pressler H., Mayer F., Kanz L., Bokemeyer C. Cisplatin-refractory HER-2/neu-expressing germ-cell cancer: induction of remission by the monoclonal antibody trastuzumab. [Letter] Ann Oncol. 10:1999;1393-1394
90. Bushby L.H., Miller F.N., Rosairo S., Clarke J.L., Sidhu P.S. Scrotal calcification: ultrasound appearances, distribution and aetiology. Br J Urol. 75:2002;283-288
91. Schmidt B., Ackermann R., Strohmeyer T. Molecular biology of testicular germ cell tumors: current status. Mol Med. 73:1995;355-367
92. Looijenga L.H., de Munnik H., Oosterhuis J.W. A molecular model for the development of germ cell cancer. [Review] Int J Cancer. 83:1999;809-814
93. Latza U., Foss H.D., Durkop H., Eitelbach F., Dieckmann K.P., Loy V., Unger M., Pizzolo G., Stein H. CD30 antigen in embryonal carcinoma and embryogenesis and release of the soluble molecule. Am J Pathol. 146:1995;463-471
94. Berney D.M., Shamash J., Pieroni H., Oliver R.T. Loss of CD30 expression in metastatic embryonal carcinoma: the effects of chemotherapy? Histopathology. 39:2001;382-385
95. Leroy X., Augusto D., Leteurtre E., Gosselin B. CD30 and CD117 (c-kit) used in combination are useful for distinguishing embryonal carcinoma from seminoma. J Histochem Cytochem. 50:2002;283-285
96. Saksela K., Makela T.P., Alitalo K. Oncogene expression in small-cell lung cancer cell lines and in a testicular germ-cell tumor: activation of the N-myc gene and decreased RB mRNA. Int J Cancer. 44:1989;182-185
97. INK4C marks progression from carcinoma in situ to invasive germ cell tumours. Int J Cancer. 85:2000;370-375
98. van Schothorst E.M., Mohkamsing S., van Gurp R.J., Oosterhuis J.W., van der Saag P.T., Looijenga L.H. Lack of Bcl10 mutations in testicular germ cell tumours and derived cell lines. Br J Cancer. 80:1999;1571-1574
99. Fakruddin J.M., Chaganti R.S., Murty V.V. Lack of BCL10 mutations in germ cell tumors and B cell lymphomas. Cell. 97:1999;683-684. discussion 686-8
100. Kakinuma H., Habuchi T., Ito T., Mishina M., Sato K., Satoh S., Akao T., Ogawa O., Kato T. BCL10 is not a major target for frequent loss of 1p in testicular germ cell tumors. Cancer Genet Cytogenet. 126:2001;134-138
101. Strohmeyer T., Klone A., Wagner G., Hartmann M., Sies H. Glutathione S-transferase expression in human testicular germ cell tumors: changes in expression and activity. J Urol. 147:1992;1424-1428
102. Klys H.S., Whillis D., Howard G., Harrison D.J. Glutathione S-transferase expression in the human testis and testicular germ cell neoplasia. Br J Cancer. 66:1992;589-593
103. Institoris E., Eid H., Bodrogi I., Bak M. Differential expression of glutathione-S-transferases in germ cell tumors of the human testes. Anticancer Res. 18:1998;1727-1732
104. Wakeman J.A., Walsh J., Andrews P.W. Human Wnt-13 is developmentally regulated during the differentiation of NTERA-2 pluripotent human embryonal carcinoma cells. Oncogene. 17:1998;179-186
105. Tainsky M.A., Cooper C.S., Giovanella B.C., Vande Woude G.F. An activated rasN gene: detected in late but not early passage human PA1 teratocarcinoma cells. Science. 225:1984;643-645
106. Jakobovits A., Schwab M., Bishop J.M., Martin G.R. Expression of N-myc in teratocarcinoma stem cells and mouse embryos. Nature. 318:1985;188-191
107. Tobaly-Tapiero J., Saal F., Peries J., Emanoil-Ravier R. Amplification and rearrangement of Ki-ras oncogene in human teratocarcinoma-derived cell lines. Biochimie. 68:1986;1019-1023
108. Mulder M.P., Keijzer W., Verkerk A., Boot A.J., Prins M.E., Splinter T.A., Bos J.L. Activated ras genes in human seminoma: evidence for tumor heterogeneity. Oncogene. 4:1989;1345-1351
109. Ganguly S., Murty V.V., Samaniego F., Reuter V.E., Bosl G.J., Chaganti R.S. Detection of preferential NRAS mutations in human male germ cell tumors by the polymerase chain reaction. Genes Chromosomes Cancer. 1:1990;228-232
110. Tesch H., Furbass R., Casper J., Lyons J., Bartram C.R., Schmoll H.J., Bronson J.L. Cellular oncogenes in human teratocarcinoma cell lines. Int J Androl. 13:1990;377-388
111. Mulder M.P., Keijzer W., Splinter T.A., Bos J.L. Frequent occurrence of activated ras oncogene in seminomas but not in nonseminomatous tumors. Oosterhuis J.W., Walt H., Damjanov I. Pathobiology of human germ cell neoplasia. 1991;125-131 Springer-Verlag, Berlin
112. Peltomaki P., Alfthan O., de la Chapelle A. Oncogenes in human testicular cancer: DNA and RNA studies. Br J Cancer. 63:1991;851-858
113. Ridanpaa M., Lothe R.A., Onfelt A., Fosså S., Børresen A.L., Husgafvel-Pursiainen K. K-ras oncogene codon 12 point mutations in testicular cancer. Environ Health Perspect. 101:(Suppl 3):1993;185-187
114. Shuin T., Misaki H., Kubota Y., Yao M., Hosaka M. Differential expression of protooncogenes in human germ cell tumors of the testis. Cancer. 73:1994;1721-1727
115. Olie R.A., Looijenga L.H., Boerrigter L., Top B., Rodenhuis S., Langeveld A., Oosterhuis J.W. N- and KRAS mutations in primary testicular germ cell tumors: incidence and possible biologic implications. Genes Chromosomes Cancer. 12:1995;110-116
116. Stoop H., van Gurp R., de Krijger R., Geurts van Kessel A., Koberle B., Oosterhuis W., Looijenga L. Reactivity of germ cell maturation stage-specific markers in spermatocytic seminoma: diagnostic and etiological implications. Lab Invest. 81:2001;919-928
117. Sugihara A., Saiki S., Tsuji M., Tsujimura T., Nakata Y., Kubota A., Kotake T., Terada N. Expression of Fas and Fas ligand in the testes and testicular germ cell tumors: an immunohistochemical study. Anticancer Res. 17:1997;3861-3865
118. Braendstrup O., Bols B., Jensen L. Fas and Fas-ligand expression in seminomatous testes. APMIS. 107:1999;431-436
119. Hara S., Miyake H., Nakamura I., Arakawa S., Kamidono S., Hara I. Increased FAS ligand expression in the tumor tissue and serum of patients with testicular germ cell tumors with seminomatous elements. Urology. 58:2001;471-476
120. Grobholz R., Zentgraf H., Kohrmann K.U., Bleyl U. Bax, Bcl-2, fas, and Fas-L antigen expression in human seminoma: correlation with the apoptotic index. APMIS. 110:2002;724-732
121. Kersemaekers A.M., van Weeren P.C., Oosterhuis J.W., Looijenga L.H. Involvement of the Fas/FasL pathway in the pathogenesis of germ cell tumours of the adult testis. J Pathol. 196:2002;423-429
122. Schmelz H.U., Abend M., Kraft K., Hauck E.W., Weidner W., van Beuningen D., Sparwasser C. Fas/Fas ligand system and apoptosis induction in testicular carcinoma. Cancer. 95:2002;73-81
123. Takayama H., Takakuwa T., Tsujimoto Y., Tani Y., Nonomura N., Okuyama A., Nagata S., Aozasa K. Frequent Fas gene mutations in testicular germ cell tumors. Am J Pathol. 161:2002;635-641
124. Misaki H., Shuin T., Yao M., Kubota Y., Hosaka M. Expression of myc family oncogenes in primary human testicular cancer. [in Japanese] Nippon Hinyokika Gakkai Zasshi. 80:1989;1509-1513
125. Devouassoux Shisheboran M., Mauduit C., Bouvier R., Berger F., Bouras M., Droz J.P., Benahmed M. Expression of hMLH1 and hMSH2 and assessment of microsatellite instability in testicular and mediastinal germ cell tumours. Mol Hum Reprod. 7:2001;1099-1105
126. van Schaik R.H., Wierikx C.D., Looijenga L.H., Oosterhuis J.W., de Jong F.H. Human testicular germ cell tumours express inhibin subunits, activin receptors and follistatin mRNAs. Br J Cancer. 76:1997;1191-1198
127. Cobellis L., Cataldi P., Reis F.M., De Palo G., Raspagliesi F., Pilotti S., Arcuri F., Petraglia F. Gonadal malignant germ cell tumors express immunoreactive inhibin/activin subunits. Eur J Endocrinol. 145:2001;779-784
128. Drescher B., Lauke H., Hartmann M., Davidoff M., Zumkeller W. Immunohistochemical pattern of insulin-like growth factor (IGF) I, IGF II, and IGF binding proteins 1 to 6 in carcinoma in situ of the testis. J Clin Pathol Mol Pathol. 50:1997;298-303
129. Hofmann M.C., Millan J.L. Developmental expression of alkaline phosphatase genes: reexpression in germ cell tumours and in vitro immortalized germ cells. [Review] Eur Urol. 23:1993;38-44. discussion 45
130. Roelofs H., Manes T., Janszen T., Millan J.L., Oosterhuis J.W., Looijenga L.H. Heterogeneity in alkaline phosphatase isozyme expression in human testicular germ cell tumours: an enzyme-/immunohistochemical and molecular analysis. J Pathol. 189:1999;236-244
131. Foster K., Osborne R.J., Huddart R.A., Affara N.A., Ferguson Smith M.A., Maher E.R. Molecular genetic analysis of the von Hippel-Lindau disease (VHL) tumour suppressor gene in gonadal tumours. Eur J Cancer. 31A:1995;2392-2395
132. Lifschitz-Mercer B., Elliott D.J., Issakov J., Leider-Trejo L., Schreiber L., Misonzhnik F., Eisenthal A., Maymon B. Localization of a specific germ cell marker, DAZL1, in testicular germ cell neoplasias. Virchows Arch. 440:2002;387-391
133. Honorio S., Agathanggelou A., Wernert N., Rothe M., Maher E.R., Latif F. Frequent epigenetic inactivation of the RASSF1A tumour suppressor gene in testicular tumours and distinct methylation profiles of seminomas and nonseminoma testicular germ cell tumours. Oncogene. 22:2003;461-466
134. Saito T., Katagiri A., Watanabe R., Tanikawa T., Kawasaki T., Tomita Y., Takahashi K. Expression of E-cadherin and catenins on testis tumor. Urol Int. 65:2000;140-143
135. Baldassarre G., Romano A., Armenante F., Rambaldi M., Paoletti I., Sandomenico C., Pepe S., Staibano S., Salvatore G., De Rosa G., Persico M.G., Viglietto G. Expression of teratocarcinoma-derived growth factor-1 (TDGF-1) in testis germ cell tumors and its effect on growth and differentiation of embryonal carcinoma cell line NTERA-2/D1. Oncogene. 15:1997;927-936
136. Eyzaguirre E., Gatalica Z. Loss of expression of Fhit expression in testicular germ cell tumors and intratubular germ cell neoplasia. Mod Pathol. 15:2002;1068-1072
137. Kraggerud S.M., Aman P., Holm R., Stenwig A.E., Fosså S.D., Nesland J.M., Lothe R.A. Alterations of the fragile histidine triad gene, FHIT, and its encoded products contribute to testicular germ cell tumorigenesis. Cancer Res. 62:2002;512-517
138. Kasahara T., Hara N., Bilim V., Tomita Y., Tsutsui T., Takahashi K. Immunohistochemical studies of caveolin-3 in germ cell tumors of the testis. Urol Int. 68:2002;63-68
139. Kamai T., Arai K., Sumi S., Tsujii T., Honda M., Yamanishi T., Yoshida K.I. The rho/rho-kinase pathway is involved in the progression of testicular germ cell tumour. BJU Int. 89:2002;449-453
140. Pero R., Lembo F., Di Vizio D., Boccia A., Chieffi P., Fedele M., Pierantoni G.M., Rossi P., Iuliano R., Santoro M., Viglietto G., Bruni C.B., Fusco A., Chiariotti L. RNF4 is a growth inhibitor expressed in germ cells but not in human testicular tumors. Am J Pathol. 159:2001;1225-1230
141. Mosselman S., Claesson-Welsh L., Kamphuis J.S., van Zoelen E.J. Developmental regulated expression of two novel platelet-derived growth factor alpha-receptor transcripts in human teratocarcinoma cells. Cancer Res. 54:1994;220-225
142. Mosselman S., Looijenga L.H., Gillis A.J., van Rooijen M.A., Kraft H.J., van Zoelen E.J., Oosterhuis J.W. Aberrant platelet-derived growth factor alpha-receptor transcript as a diagnostic marker for early human germ cell tumors of the adult testis. Proc Natl Acad Sci U S A. 93:1996;2884-2888
143. Kraft H.J., Mosselman S., Smits H.A. Oct-4 regulates alternative platelet-derived growth factor alpha receptor gene promoter in human embryonal carcinoma cells. J Biol Chem. 271:1996;12873-12878
144. Palumbo C., van Roozendaal K., Gillis A.J., van Gurp R.H., de Munnik H., Oosterhuis J.W., van Zoelen E.J., Looijenga L.H. Expression of the PDGF alpha-receptor 1.5 kb transcript, OCT-4, and c-KIT in human normal and malignant tissues: implications for the early diagnosis of testicular germ cell tumours and for our understanding of regulatory mechanisms. J Pathol. 196:2002;467-477
145. Matsuda R., Takahashi T., Nakamura S., Sekido Y., Nishida K., Seto M., Seito T., Sugiura T., Ariyoshi Y., Takahashi T., Ueda R. Expression of the c-kit protein in human solid tumors and in corresponding fetal and adult normal tissues. Am J Pathol. 142:1993;339-346
146. Tsuura Y., Hiraki H., Watanabe K., Igarashi S., Shimamura K., Fukuda T., Seito T. Preferential localization of c-kit product in tissue mast cells, basal cells of skin, epithelial cells of breast, small cell lung carcinoma and seminoma/dysgerminoma in human: immunohistochemical study of formalin-fixed, paraffin-embedded tissues. Virchows Arch. 424:1994;135-141
147. Fleischhacker M., Strohmeyer T., Imai Y., Slamon D., Koeffler H.P. Mutations in the p53 gene are not detectable on human testicular cancer. Mod Pathol. 7:1994;435-439
148. Izquierdo M.A., van der Valk P., van Ark Otte J., Rubio G., Germa Lluch J.R., Ueda R., Scheper R.J., Takahashi T., Giaccone G. Differential expression of the c-kit proto-oncogene in germ cell tumours. J Pathol. 177:1995;253-258
149. Strohmeyer T., Reese D., Press M., Ackermann R., Hartmann M., Slamon D. Expression of the c-kit proto-oncogene and its ligand stem cell factor (SCF) in normal and malignant human testicular tissue. J Urol. 153:1995;511-515
150. Bokemeyer C., Kuczyk M.A., Dunn T., Serth J., Hartmann K., Jonasson J., Pietsch T., Jonas U., Schmoll H.J. Expression of stem-cell factor and its receptor c-kit protein in normal testicular tissue and malignant germ-cell tumours. J Cancer Res Clin Oncol. 122:1996;301-306
151. Chou P.M., Barquin N., Guinan P., Ridaura-Sanz C., Gonzalez-Crussi F. Differential expression of p53, c-kit, and CD34 in prepubertal and postpubertal testicular germ cell tumors. Cancer. 79:1997;2430-2434
152. Kraggerud S., Berner A., Bryne M., Pettersen E.O., Fosså S.D. Spermatocytic seminoma as compared to classical seminoma: an immunohistochemical and DNA flow cytometric study. APMIS. 107:1999;297-302
153. Tian Q., Frierson H.F. Jr., Krystal G.W., Moskaluk C.A. Activating c-kit gene mutations in human germ cell tumors. Am J Pathol. 154:1999;1643-1647
154. Berney D.M., Shamash J., Gaffney J., Jordan S., Oliver R.T. DNA
155. Leroy X., Augusto D., Leteurtre E., Gosselin B. CD30 and CD117 (c-kit) used in combination are useful for distinguishing embryonal carcinoma from seminoma. J Histochem Cytochem. 50:2002;283-285
156. Moroni M., Veronese S., Schiavo R., Carminati O., Sørensen B.S., Gambacorta M., Siena S. Epidermal growth factors receptor expression and activation in nonseminomatous germ cell tumors. Clin Cancer Res. 7:2001;2770-2775
157. Mayer F., Stoop H., Scheffer G.L., Scheper R., Oosterhuis J.W., Looijenga L.H., Bokemeyer C. Molecular determinants of treatment response in human germ cell tumors. Clin Cancer Res. 9:2003;767-773
158. Bouras M., Tabone E., Bertholon J., Sommer P., Bouvier R., Droz J.P., Benahmed M. A novel SMAD4 gene mutation in seminoma germ cell tumors. Cancer Res. 60:2000;922-928
159. Bala S., Oliver H., Renault B., Montgomery K., Dutta S., Rao P., Houldsworth J., Kucherlapati R., Wang X., Chaganti R.S., Murty V.V. Genetic analysis of the APAF1 gene in male germ cell tumors. Genes Chromosomes Cancer. 28:2000;258-268
160. Schrader M., Burger A.M., Muller M., Krause H., Straub B., Schostak M., Schulze W., Lauke H., Miller K. The differentiation status of primary gonadal germ cell tumors correlates inversely with telomerase activity and the expression level of the gene encoding the catalytic subunit of telomerase. BMC Cancer. 2:2002;32-41
161. Cressey T.R., Tilby M.J., Newell D.R. Decreased telomerase activity is not a reliable indicator of chemosensitivity in testicular cancer cell lines. Eur J Cancer. 38:2002;586-593
162. Zeeman A.M., Stoop H., Boter M. VASA is a specific marker for both normal and malignant human germ cells. Lab Invest. 82:2002;159-166
163. von Deimling F., Scharf J.M., Liehr T., Rothe M., Kelter A.R., Albers P., Dietrich W.F., Kunkel L.M., Wernert N., Wirth B. Human and mouse RAD17 genes: identification, localization, genomic structure and histological expression pattern in normal testis and seminoma. Hum Genet. 105:1999;17-27
164. Peng H.Q., Bailey D., Bronson D., Goss P.E., Hogg D. Loss of heterozygosity of tumor suppressor genes in testis cancer. Cancer Res. 55:1995;2871-2875
165. Wang C., Uchida T., Satoh T., Irie A., Soh S., Iwamura M., Okori M., Koshiba K. Mutations of p53 gene and genomic instability in testicular tumors. [in Japanese] Nippon Hinyokika Gakkai Zasshi. 89:1998;780-787
166. Rothe M., Albers P., Wernert N. Loss of heterozygosity, differentiation, and clonality in microdissected male germ cell tumours. J Pathol. 188:1999;389-394
167. Spermon J.R., De Wilde P.C., Hanselaar A.G., Schaafsma H.E., Ruijter T.E., Witjes J.A., van Moorselaar R.J. α-Catenin expression pattern and DNA image-analysis cytometry have no additional value over primary histology in clinical stage I nonseminomatous testicular cancer. BJU Int. 89:2002;278-284
168. Suzuki N., Yamada T., Matsuoka K., Hiraoka N., Iwamaru Y., Hata J. Functional expressions of fms and M-CSF during trophoectodermal differentiation of human embryonal carcinoma cells. Placenta. 20:1999;203-211
169. Przyborski S.A., Damjanov I., Knowles B.B., Ackerman S.L. Differential expression of the zinc finger gene TCF17 in testicular tumors. Cancer Res. 58:1998;4598-4601
170. Brehm A., Ovitt C.E., Scholer H.R. Oct-4: more than just a POUerful marker of the mammalian germline? [Review] APMIS. 106:1998;114-124. discussion 124-6
171. Looijenga L.H., Stoop H., de Leeuw H.P., Gouveia Brazao C.A., Gillis A.J., van Roozendaal K.E., van Zoelen E.J., Weber R.F., Wolffenbuttel K.P., van Dekken H., Honecker F., Bokemeyer C., Perlman E.J., Schneider D.T., Kononen J., Sauter G., Oosterhuis J.W. POU5F1 (OCT 3/4) identifies cells with pluripotent potential in human germ cell tumors. Cancer Res. 63:2003;2244-2250
172. Burger H., Nooter K., Boersma A.W., Kortland C.J., van den Berg A.P., Stoter G. Expression of p53, p21/WAF/CIP, Bcl-2, Bax, Bcl-X, and Bak in radiation-induced apoptosis in testicular germ cell tumor lines. Int J Radiat Oncol Biol Phys. 41:1998;415-424
173. Chresta C.M., Masters J.R., Hickman J.A. Hypersensitivity of human testicular tumors to etoposide-induced apoptosis is associated with functional p53 and high bax:bcl-2 ratio. Cancer Res. 56:1996;1834-1841
174. Guillou L., Estreicher A., Chaubert P., Hurlimann J., Kurt A.M., Metthez G., Iggo R., Gray A.C., Jichlinski P., Leisinger H.J., Benhattar J. Germ cell tumors of the testis overexpress wild-type p53. Am J Pathol. 149:1996;1221-1228
175. Houldsworth J., Reuter V., Bosl G.J., Chaganti R.S. Aberrant expression of cyclin D2 is an early event in human male germ cell tumorigenesis. Cell Growth Differ. 8:1997;293-299
176. Houldsworth J., Xiao H., Murty V.V., Chen W., Ray B., Reuter V.E., Bosl G.J., Chaganti R.S. Human male germ cell tumor resistance to cisplatin is linked to TP53 gene mutation. Oncogene. 16:1998;2345-2349
177. Arriola E.L., Lopez A.R., Chresta C.M. Differential regulation of p21waf-1/cip-1 and Mdm2 by etoposide: etoposide inhibits the p53-Mdm2 autoregulatory feedback loop. Oncogene. 18:1999;1081-1091
178. Burger H., Nooter K., Boersma A.W., Van Wingerden K.E., Looijenga L.H., Jochemsen A.G., Stoter G. Distinct p53-independent apoptotic cell death signalling pathways in testicular germ cell tumour cell lines. Int J Cancer. 81:1999;620-628
179. Datta M.W., Macri E., Signoretti S., Renshaw A.A., Loda M. Transition from in situ to invasive testicular germ cell neoplasia is associated with the loss of p21 and gain of mdm-2 expression. Mod Pathol. 14:2001;437-442
180. Bartkova J., Rajpert-De Meyts E., Skakkebaek N.E., Bartek J. D-type cyclins in adult human testis and testicular cancer: relation to cell type, proliferation, differentiation, and malignancy. J Pathol. 187:1999;573-581
181. Viglietto G., Romano A., Maglione D., Rambaldi M., Paoletti I., Lago C.T., Califano D., Monaco C., Mineo A., Santelli G., Manzo G., Botti G., Chiappetta G., Persico M.G. Neovascularization in human germ cell tumors correlates with marked increase in the expression of the vascular endothelial growth factor but not the placenta-derived growth factor. Oncogene. 13:1996;577-587
182. Fukuda S., Shirahama T., Imazono Y., Tsushima T., Ohmori H., Kayajima T., Take S., Nishiyama K., Yonezawa S., Akiba S., Akiyama S., Ohi Y. Expression of vascular endothelial growth factor in patients with testicular germ cell tumors as an indicator of metastatic disease. Cancer. 85:1999;1323-1330
183. Strohmeyer T., Klone A., Wagner G., Hartmann M., Sies H. Glutathione S-transferase expression in human testicular germ cell tumors: changes in expression and activity. J Urol. 147:1992;1424-1428
184. Brehm R., Marks A., Rey R., Kliesch S., Bergmann M., Steger K. Altered expression of connexins 26 and 43 in Sertoli cells in seminiferous tubules infiltrated with carcinoma-in-situ or seminoma. J Pathol. 197:2002;647-653
185. Peltomaki P., Halme A., de la Chapelle A. Human testicular cancer: changes in autosomal dosage. Cancer Genet Cytogenet. 48:1990;1-12
186. Katagiri A., Tomita Y., Nishiyama T., Kimura M., Sato S. Immunohistochemical detection of P-glycoprotein and GSTP1-1 in testis cancer. Br J Cancer. 68:1993;125-129
187. Eid H., Mingfang L., Institoris E., Bodrogi I., Bak M. MRP expression of testicular cancers and its clinical relevance. Anticancer Res. 20:2000;4019-4022
188. Schmidt B.A., Rose A., Steinhoff C., Strohmeyer T., Hartmann M., Ackermann R. Up-regulation of cyclin-dependent kinase 4/cyclin D2 expression but down-regulation of the cyclin-dependent kinase 2/cyclin E in testicular germ cell tumors. Cancer Res. 61:2001;4214-4221
189. Suzuki K., Tokue A., Kamiakito T., Kuriki K., Saito K., Tanaka A. Predominant expression of fibroblast growth factor (FGF) 8, FGF4, and FGF receptor 1 in nonseminomatous and highly proliferative components of testicular germ cell tumors. Virchows Arch. 439:2001;616-621
190. Sikora K., Evan G., Stewart J., Watson J.V. Detection of the c-myc oncogene product in testicular cancer. Br J Cancer. 52:1985;171-176
191. Watson J.V., Stewart J., Evan G.I., Ritson A., Sikora K. The clinical significance of flow cytometric c-myc oncoprotein quantitation in testicular cancer. Br J Cancer. 53:1986;331-337
192. Taverna P., Hansson J., Scanlon K.J., Hill B.T. Gene expression in X-irradiated human tumor cell lines expressing cisplatin resistance and altered DNA repair capacity. Carcinogenesis. 15:1994;2053-2060
193. Schmidt B., Ackermann R., Hartmann M., Strohmeyer T. Alterations of the metastasis suppressor gene nm23 and the proto-oncogene c-myc in human testicular tumors. J Urol. 158:1997;2000-2005
194. Hatta Y., Hirama T., Takeuchi S., Lee E., Pham E., Miller C.W., Strohmeyer T., Wilczynski S., Melmed S., Koeffler H.P. Alterations of the p16 (MTS1) gene in testicular, ovarian, and endometrial malignancies. J Urol. 154:1995;1954-1957
195. INK4 (MTS1) gene inactivation in testicular germ cell tumors. Am J Pathol. 151:1997;859-865
196. Bartkova J., Lukas C., Sorensen C.S., Rajpert-De Meyts E., Skakkebaek N.E., Lukas J., Bartek J. Deregulation of the RB pathway in human testicular germ cell tumours. J Pathol. 200:2003;149-156
197. INK4B/MTS2 genes in primary human testicular germ cell tumors. J Urol. 159:1998;1725-1730
198. Koberle B., Masters J.R., Hartley J.A., Wood R. Defective repair of cisplatin-induced DNA damage caused by reduced XPA protein in testicular germ cell tumours. Curr Biol. 9:1999;273-276
199. Teng D.H., Hu R., Lin H., Davis T., Iliev D., Frye C., Swedlund B., Hansen K.L., Vinson V.L., Gumpper K.L., Ellis L., El-Naggar A., Frazier M., Jasser S., Langford L.A., Lee J., Mills G.B., Pershouse M.A., Pollack R.E., Tornos C., Troncoso P., Yung W.K., Fujii G., Berson A., Bookstein R., Bolen J.B., Tavtigian S.V., Steck P.A. MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines. Cancer Res. 57:1997;5221-5225
200. 6-methylguanine-DNA methyltransferase (MGMT) gene in testicular cancer. Oncogene. 21:2002;8878-8884
201. Brookes S., Smith R., Casey G., Dickson C., Peters G. Sequence organization of the human int-2 gene and its expression in teratocarcinoma cells. Oncogene. 4:1989;429-436
202. Heidenreich A., Sesterhenn I.A., Mostofi F.K., Moul J.W. Prognostic risk factors that identify patients with clinical stage I nonseminomatous germ cell tumors at low risk and high risk for metastasis. Cancer. 83:1998;1002-1011
203. van Gurp R.J., Oosterhuis J.W., Kalscheuer V., Mariman E.C., Looijenga L.H. Biallelic expression of the H19 and IGF2 genes in human testicular germ cell tumors. J Natl Cancer Inst. 86:1994;1070-1075
204. Ariel I., Ayesh S., Perlman E.J., Pizov G., Tanos V., Schneider T., Erdmann A., Podeh D., Komitowski D., Qasem A.S., de Groot N., Hochberg A. The product of the imprinted H19 gene is an oncofetal RNA. Mol Pathol. 50:1997;34-44
205. Nonomura N., Miki T., Nishimura K., Kanno N., Kojima Y., Okuyama A. Altered imprinting of the H19 and insulin-like growth factor II genes in testicular tumors. J Urol. 157:1997;1977-1979
206. Verkerk A.J., Ariel I., Dekker M., Schneider T., van Gurp R.J., de Groot N., Gillis A.J., Oosterhuis J.W., Hochberg A.A., Looijenga L.H. Unique expression patterns of H19 in human testicular cancers of different etiology. Oncogene. 14:1997;95-107
207. Byrialsen A., von Eyben F.E., Kristiansen K. Carcinoma in situ of the testis and seminoma express a high protein level of lactate dehydrogenase subunit B but no subunit C. J Tumor Marker Oncol. 13:1998;79-86
208. Looijenga L.H., Abraham M., Gillis A.J., Saunders G.F., Oosterhuis J.W. Testicular germ cell tumors of adults show deletions of chromosome bands 11p13 and 11p15, but no abnormalities within the zinc-finger regions and exons 2 and 6 of the Wilms' tumor 1 gene. Genes Chromosomes Cancer. 9:1994;153-160
209. Nonomura N., Imazu T., Harada Y., Nozawa M., Ono Y., Fukui T., Nishimura K., Okuyama A. Molecular staging of testicular cancer using polymerase chain reaction of the testicular cancer-specific genes. [in Japanese] Hinyokika Kiyo. Acta Urol Jpn. 45:1999;593-597
210. Siegrist S., Feral C., Chami M., Solhonne B., Mattei M.G., Rajpert-De Meyts E., Guellaen G., Bulle F. hH-Rev107, a class II tumor suppressor gene, is expressed by post-meiotic testicular germ cells and CIS cells but not by human testicular germ cell tumors. Oncogene. 20:2001;5155-5163
211. Harries L.W., Stubbins M.J., Forman D., Howard G.C., Wolf C.R. Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis. 18:1997;641-644
212. Yoshida T., Tsutsumi M., Sakamoto H., Miyagawa K., Teshima S., Sugimura T., Terada M. Expression of the HST1 oncogene in human germ cell tumors. [Erratum: Biochem Biophys Res Commun 1988;157:850.] Biochem Biophys Res Commun. 155:1988;1324-1329
213. Sicinski P., Donaher J.L., Geng Y., Parker S.B., Gardner H., Park M.Y., Robker R.L., Richards J.S., McGinnis L.K., Biggers L.D., Eppig J.J., Bronson R.T., Elledge S.J., Weinberg R.A. Cyclin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesis. Nature. 384:1996;470-474
214. Kukoski R., Blonigen B., Macri E., Renshaw A.A., Hoffman M., Loda M., Datta M.W. p27 and cyclin E/D2 associations in testicular germ cell tumors. Appl Immunohistochem Mol Morphol. 11:2003;138-143
215. Fosså S.D., Klepp O., Paus E. Neuron-specific enolase - a serum tumour marker in seminoma? Br J Cancer. 65:1992;297-299
216. Caricasole A.A., van Schaik R.H., Zeinstra L.M., Wierikx C.D., van Gurp R.J., van den Pol M., Looijenga L.H., Oosterhuis J.W., Pera M.F., Ward A., de Bruijn D. Kramer P, de Jong FH, van der Eijnden-van Raij AJ. Human growth-differentiation factor 3 (hGDF3): developmental regulation in human teratocarcinoma cell lines and expression in primary testicular germ cell tumours. Oncogene. 16:1998;95-103
217. von Eyben F.E., Blaabjerg O., Petersen P.H., Mommsen S., Madsen E.L., Kirpekar F., Li S.S., Kristiansen K. Lactate dehydrogenase isoenzyme 1 in testicular germ cell tumors. Oosterhuis J.W., Walt H., Damjanov I. Pathobiology of human germ cell neoplasia. 1991;85-92 Springer-Verlag, Berlin
218. Bourdon V., Naef F., Rao P.H., Reuter V., Mok S.C., Bosl G.J., Koul S., Murty V.V., Kucherlapati R.S., Chaganti R.S. Genomic and expression analysis of the 12p11-p12 amplicon using EST arrays identifies two novel amplified and overexpressed genes. Cancer Res. 62:2002;6218-6223
219. Zafarana G., Gillis A.J., van Gurp R.J., Olsson P.G., Elstrodt F., Stoop H., Millan J.L., Oosterhuis J.W., Looijenga L.H. Coamplification of DAD-R, SOX5, and EKI1 in human testicular seminomas, with specific overexpression of DAD-R, correlates with reduced levels of apoptosis and earlier clinical manifestation. Cancer Res. 62:2002;1822-1831
220. Wang L.C., Vass W., Gao C.L., Chang K.S. Amplification and enhanced expression of the c-Ki-ras-2 protooncogene in human embryonal carcinomas. Cancer Res. 47:1987;4192-4198
221. Dmitrovsky E., Murty V.V., Moy D., Miller W.H., Nanus D., Albino A.P., Samaniego F., Bosl G., Chaganti R.S. Isochromosome 12p in non-seminoma cell lines: karyologic amplification of c-ki-ras2 without point-mutational activation. Oncogene. 5:1990;543-548
222. Moul J.W., Theune S.M., Chang E.H. Detection of RAS mutations in archival testicular germ cell tumors by polymerase chain reaction and oligonucleotide hybridization. Genes Chromosomes Cancer. 5:1992;109-118
223. Roelofs H., Mostert M.C., Pompe K., Zafarana G., van Oorschot M., van Gurp R.J., Gillis A.J., Stoop H., Beverloo B., Oosterhuis J.W., Bokemeyer C., Looijenga L.H. Restricted 12p amplification and RAS mutation in human germ cell tumors of the adult testis. Am J Pathol. 157:2000;1155-1166
224. Riou G., Barrois M., Prost S., Terrier M.J., Theodore C., Levine A.J. The p53 and mdm-2 genes in human testicular germ-cell tumors. Mol Carcinog. 12:1995;124-131
225. Kersemaekers A.M., Mayer F., Molier M., van Weeren P.C., Oosterhuis J.W., Bokemeyer C., Looijenga L.H. Role of P53 and MDM2 in treatment response of human germ cell tumors. J Clin Oncol. 20:2002;1551-1561
226. Qiao D., Zeeman A.M., Deng W., Looijenga L.H., Lin H. Molecular characterization of hiwi, a human member of the piwi gene family whose overexpression is correlated to seminoma. Oncogene. 21:2002;3988-3999
227. Muller-Tidow C., Diederichs S., Schrader M.G., Vogt U., Miller K., Berdel W.E., Serve H. Cyclin A1 is highly expressed in aggressive testicular germ cell tumors. Cancer Lett. 190:2003;89-95
228. Strohmeyer T., Reissmann P., Cordon Cardo C., Hartmann M., Ackermann R., Slamon D. Correlation between retinoblastoma gene expression and differentiation in human testicular tumors. Proc Natl Acad Sci U S A. 88:1991;6662-6666
229. Robertson K.A., Bullock H.A., Xu Y., Tritt R., Zimmerman E., Ulbright T.M., Foster R.S., Einhorn L.H., Kelley M.R. Altered expression of Ape1/ref-1 in germ cell tumors and overexpression of NT2 cells confers resistance to bleomycin and radiation. Cancer Res. 61:2001;2220-2225
230. Baou N., Bouras M., Droz J.P., Dutrieux-Berger N., Bouvier R., Benahmed M., Krantic S. Somatostatin receptor expression profile as a potential criterion for discrimination between seminoma and non-seminoma testicular tumors. Cancer Detect Prev. 25:2001;446-453
231. Rorth M., Rajpert-De Meyts E., Andersson L., Dieckmann K.P., Fosså S.D., Grigor K.M., Hendry W.F., Herr H.W., Looijenga L.H., Oosterhuis J.W., Skakkebaek N.E. Carcinoma in situ in the testis. [Review] Scand J Urol Nephrol. Suppl 205:2000;166-186
232. Bartkova J., Bartek J., Lukas J., Vojtesek B., Staskova Z., Rejthar A., Kovarik J., Midgley C.A., Lane D.P. p53 protein alterations in human testicular cancer including pre-invasive intratubular germ-cell neoplasia. Int J Cancer. 49:1991;196-202
233. Heimdal K., Lothe R., Lystad S., Holm R., Fosså S.D., Børresen A.L. No germline p53 mutations detected in familial and bilateral testicular cancer. Genes Chromosomes Cancer. 6:1993;92-97
234. Bouras M., Tabone E., Bertholon J., Sommer P., Bouvier R., Droz J.P., Benahmed M. A novel SMAD4 gene mutation in seminoma germ cell tumors. Cancer Res. 60:2000;922-928
235. Wei Y.D., Jiafu Z., Xi Q.S., Yongjang M., Xiulong Z., Daizong L., Jianren G. p53 gene mutations in chinese human testicular seminoma. J Urol. 150:1993;884-886
236. Kuczyk M.A., Serth J., Bokemeyer C., Allhoff E.P., Jonassen J., Kuczyk S., Jonas U. Overexpression of the p53 oncoprotein in carcinoma in situ of the testis. Pathol Res Pract. 190:1994;993-998
237. Lewis D.J., Sesterhenn I.A., McCarthy W.F., Moul J.W. Immunohistochemical expression of p53 tumor suppressor gene protein in adult germ cell testis tumors: clinical correlation in stage I disease. J Urol. 152:1994;418-423
238. Ulbright T.M., Orazi A., de Riese W., de Riese C., Messemer J.E., Foster R.S., Donohue J.P., Eble J.N. The correlation of p53 protein expression with proliferative activity and occult metastases in clinical stage I non-seminomatous germ cell tumors of the testis. Mod Pathol. 7:1994;64-68
239. Albers P., Orazi A., Ulbright T.M., Miller G.A., Haidar J.H., Donohue J.P., Foster R.S. Prognostic significance of immunohistochemical proliferation markers (Ki-67/MIB-1 and proliferation-associated nuclear antigen), p53 protein accumulation, and neovascularization in clinical stage A nonseminomatous testicular germ cell tumors. Mod Pathol. 8:1995;492-497
240. Schenkman N.S., Sesterhenn I.A., Washington L., Tong Y.A., Weghorst C.M., Buzard G.S., Srivastava S., Moul J.W. Increased p53 protein does not correlate to p53 gene mutations in microdissected human testicular germ cell tumors. J Urol. 154:1995;617-621
241. Kuczyk M.A., Serth J., Bokemeyer C., Jonassen J., Machtens S., Werner M., Jonas U. Alterations of the p53 tumor suppressor gene in carcinoma in situ of the testis. Cancer. 78:1996;1958-1966
242. Soini Y., Paakko P. Extent of apoptosis in relation to p53 and bcl-2 expression in germ cell tumors. Hum Pathol. 27:1996;1221-1226
243. Eid H., van der Looij M., Institoris E., Geczi L., Bodrogi I., Olah E., Bak M. Is p53 expression, detected by immunohistochemistry, an important parameter of response to treatment in testis cancer? Anticancer Res. 17:1997;2663-2669
244. Baltaci S., Orhan D., Turkolmez K., Beduk Y., Tulunay O. P53, bcl-2 and bax immunoreactivity as predictors of response and outcome after chemotherapy for metastatic germ cell testicular tumours. BJU Int. 87:2001;661-666
245. Soule S., Baldridge L., Kirkpatrick K., Cheng L., Gilbert J.L., Smith L.R., Thurston V.C., Vance G.H., Einhorn L., Miller K. Her-2/neu expression in germ cell tumours. J Clin Pathol. 55:2002;656-658
246. Ueno M., Nakashima J., Nakahoma T., Higashi T., Hirata R., Iida M., Suzuki M., Sano M., Yamada Y., Deguchi N. Retinoic acid-induced cell growth inhibition and differentiation in testicular carcinoma cells in culture. Hum Cell. 10:1997;151-158. [in Japanese]
247. Bottero L., Simeone A., Arcioni L., Acampora D., Andrews P.W., Boncinelli E., Mavilio F. Differential activation of homeobox genes by retinoic acid in human embryonal carcinoma cells. Oosterhuis J.W., Walt H., Damjanov I. Pathobiology of human germ cell neoplasia. 1991;133-143 Springer-Verlag, Berlin
248. Backer J.M., Murty V.V., Potla L., Mendola C.E., Rodriguez E., Reuter V.E., Bosl G.J., Chaganti R.S. Loss of heterozygosity and decreased expression of NME genes correlate with teratomatous differentiation in human male germ cell tumors. Biochem Biophys Res Commun. 202:1994;1096-1103
249. Tienari J., Pertovaara L., Saksela O., Lehtonen E., Vartio T. Increased expression of the matrix metalloproteinase 2 in differentiating Tera 2 human embryonal carcinoma cells. Int J Cancer. 56:1994;219-223
250. Murty V.V., Li R.G., Houldsworth J., Bronson D.L., Reuter V.E., Bosl G.J., Chaganti R.S. Frequent allelic deletions and loss of expression characterize the DCC gene in male germ cell tumors. Oncogene. 9:1994;3227-3231
251. Strohmeyer D., Langenhof S., Ackermann R., Hartmann M., Strohmeyer T., Schmidt B. Analysis of the tumor suppressor gene DCC in testicular germ cell tumors: mutations and loss of expression. J Urol. 157:1997;1973-1976
252. Boersma A.W., Nooter K., Burger H., Kortland C.J., Stoter G. Bax upregulation is an early event in cisplatin-induced apoptosis in human testicular germ cell tumor cell line NT2 as quantitated by flow cytometry. Cytometry. 37:1997;275-282
253. Burger H., Nooter K., Boersma A.W., Kortland C.J., Stoter G. Expression of p53, Bcl-2 and Bax in cisplatin-induced apoptosis in testicular germ cell tumour cell lines. Br J Cancer. 77:1998;1562-1567
254. L and sensitizes human testicular germ cell tumours to chemotherapy-induced apoptosis. Oncogene. 18:1999;1457-1464
255. Avizienyte E., Roth S., Loukola A., Hemminki A., Lothe R.A., Stenwig A.E., Fosså S.D., Salovaara R., Aaltonen L.A. Somatic mutations in LKB1 are rare in sporadic colorectal and testicular tumors. Cancer Res. 58:1998;2087-2090
256. Ylikorkala A., Avizienyte E., Tomlinson I.P., Tiainen M., Roth S., Loukola A., Hemminki A., Johansson M., Sistonen P., Markie D., Neale K., Phillips R., Zauber P., Twama T., Sampson J., Jarvinen H., Makela T.P., Aaltonen L.A. Mutations and impaired function of LKB1 in familial and non-familial Peutz-Jeghers syndrome and a sporadic testicular cancer. Hum Mol Genet. 8:1999;45-51
257. Cardillo M.R., Petrangeli E., Ravenna L., Salvatori L., Di Silverio F. Transforming growth factor beta expression in human testicular neoplasms. Anal Quant Cytol Histol. 20:1998;461-469
258. Scorilas A., Yousef G.M., Jung K., Rajpert-De Meyts E., Carsten S., Diamandis E.P. Identification and characterization of a novel human testis-specific kinase substrate gene which is downregulated in testicular tumors. Biochem Biophys Res Commun. 285:2001;400-408
259. Yousef G.M., Obiezu C.V., Jung K., Stephan C., Scorilas A., Diamandis E.P. Differential expression of kallikrein gene 5 in cancerous and normal testicular tissues. Urology. 60:2002;714-718
260. Luo L.Y., Rajpert-De Meyts E., Jung K., Diamandis E. Expression of the normal epithelial cell-specific 1 (NES1; KLK10) candidate tumour suppressor gene in normal and malignant testicular tissue. Br J Cancer. 85:2001;220-224
261. Chang A., Yousef G.M., Jung K., Rajpert-De Meyts E., Diamandis E.P. Identification and molecular characterization of five novel kallikrein gene 13 (KLK13; KLK-L4) splice variants: differential expression in the human testis and testicular cancer. Anticancer Res. 21:2001;3147-3152
262. Schnieders F., Dork T., Arnemann J., Werner M., Schmidtke J. Testis-specific protein, Y-encoded (TSPY) expression in testicular tissues. Hum Mol Genet. 5:1996;1801-1807
263. Lau Y.F., Chou P.M., Iezzoni J.C., Alonzo J.A., Komuves L.G. Expression of a candidate gene for the gonadoblastoma locus in gonadoblastoma and testicular seminoma. Cytogenet Cell Genet. 91:2000;160-164
264. Bianchi N.O., Richard S.M., Peltomaki P., Bianchi M.S. Mosaic AZF deletions and susceptibility to testicular tumors. Mutat Res. 503:2002;51-62
265. Lifschitz-Mercer B., Elliott D.J., Leider-Trejo L., Schreiber-Bramante L., Hassner A., Eisenthal A., Maymon B.B. Absence of RBM expression as a marker of intratubular (in situ) germ cell neoplasia of the testis. Hum Pathol. 31:2000;1116-1120
266. Lykkesfeldt G., Hoyer H., Ibsen H.H., Brandrup F. Steroid sulphatase deficiency disease. Clin Genet. 28:1985;231-237
267. Kawakami T., Okamoto K., Sugihara H., Hattori T., Reeve A.E., Ogawa O., Okada Y. The roles of supernumerical X chromosomes and XIST expression in testicular germ cell tumors. J Urol. 169:2003;1546-1552
268. Rajpert-De Meyts E., Leffers H., Daugaard G., Andersen C.B., Petersen P.M., Hinrichsen J., Pedersen L.G., Skakkebaek N.E. Analysis of the polymorphic CAG repeat length in the androgen receptor gene in patients with testicular germ cell cancer. Int J Cancer. 102:2002;201-204
269. Aubry F., Satie A.P., Rioux-Leclercq N., Rajpert-De Meyts E., Spagnoli G.C., Chomez P., De Backer O., Jegou R., Samson M. MAGE-A4, a germ cell specific marker, is expressed differentially in testicular tumors. Cancer. 92:2001;2778-2785
270. Hara I., Hara S., Miyake H., Yamanaka K., Nagai H., Gohji K., Arakawa S., Kamidono S. Expression of MAGE genes in testicular germ cell tumors. Urology. 54:1999;843-847
271. Satie A.P., Rajpert-De Meyts E., Spagnoli G.C., Henno S., Olivo L., Jacobsen G.K., Rioux-Leclercq N., Jegou B., Samson M. The cancer-testis gene, NY-ESO-1, is expressed in normal fetal and adult testes and in spermatocytic seminomas and testicular carcinoma in situ. Lab Invest. 82:2002;775-780
272. Peltomaki P. DNA methylation changes in human testicular cancer. Biochim Biophys Acta. 1096:1991;187-196
273. Smiraglia D., Szymanska J., Kraggerud S.M., Lothe R.A., Peltomaki P., Plass C. Distinct epigenetic phenotypes in seminomatous and nonseminomatous testicular germ cell tumors. Oncogene. 21:2002;3909-3916
274. Peltomaki P., Halme A., de la Chapelle A. Molecular studies of the sex chromosomes in human testicular cancer: pronounced changes in X and Y chromosome dosage in some tumors. Genes Chromosomes Cancer. 1:1989;42-47
275. Peltomaki P., Lothe R., Børresen A.L., Fosså S.D., Brogger A., de la Chapelle A. Altered dosage of the sex chromosomes in human testicular cancer: a molecular genetic study. Int J Cancer. 47:1991;518-522